Human coagulation factor VIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven(r) emergency-use programme in patients with severe haemophilia or with acquired inhibitors - Arkin,S.; Blei,F.; Fetten,J. (Blood Coagul Fibrinolysis, 2000)